Cited by 69Antifungal resistance and susceptibilityNeutropenia and Cancer InfectionsFungal Infections and Studies

Risk factors for death among cancer patients with fungemia

Open access
Nucci, Marcio, Silveira, Maria Isabel, Spector, Nelson, Silveira, Fernanda, Velasco, Eduardo, Akiti, Tiyomi, Barreiros, Gloria, Derossi, Andrea +2 more·1998·Clinical Infectious Diseases

Abstract

In order to identify prognostic factors for death among cancer patients with fungemia, an 18-month survey of fungemia in patients with cancer was undertaken in three hospitals in Rio de Janeiro. For the assessment of risk factors for death, the following variables were analyzed: age; gender; underlying cancer; last treatment for the underlying disease; previous surgery; use of antibiotics, antifungal agents, steroids, or total parenteral nutrition; use of a central venous catheter; chemotherapy; radiotherapy; presence and duration of neutropenia; etiologic agent of the fungemia; treatment of the fungemia; clinical manifestations; and performance status (Karnofsky score) on the day of the positive blood culture. In multivariate analysis, the variables associated with an increased risk for death were older age, persistent neutropenia, and low performance status. Identifying risk factors for death may help to define a group-risk patients for whom new therapeutic options should be tried.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/514609

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A few studies have questioned these recommendations, failing to find a significant mortality benefit with prompt removal of the line and advising that removal and placement of a new device does not come without risk and cost.

    “A few studies have questioned these recommendations, failing to find a significant mortality benefit with prompt removal of the line and advising that removal and placement of a new device does not come without risk and cost.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. EH, Balows A, Hausler WJ Jr, Shadomy HJ, eds. Manual of clinical Dis 1985; 7:646 -55.
  2. Colombo AL, Nucci M, Caiuby MJ, et al. High incidence of non-albicans 26. Abi-Said D, Uzum O, Anaissie E. Use of severity score indexes for strati- candidemia despite rare use of azoles [abstract no J045]. In: Program fication of prognosis in hospitalized cancer patients with candidemia and abstracts of the 36th Interscience Conference on Antimicrobial [abstract no J43]. In: Program and abstracts of the 36th Interscience Agents and Chemotherapy (New Orleans). Washington, DC: American Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1996:226. Society for Microbiology, 1996:226.

Cited by

Sorted by citations

Authors
Nucci, M., Silveira, M. I., Spector, N., Silveira, F., Velasco, E., Akiti, T., Barreiros, G., Derossi, A., Colombo, A. L., & Pulcheri, W.
Affiliations
Universidade Federal do Rio de Janeiro (BR)
Venue
Clinical Infectious Diseases
Published
1998-07
Volume
27
Issue
1
Pages
107-111
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2131920567
Cited by
69
References
22
Citations by year
2025: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 1 · 2015: 2 · 2014: 2 · 2013: 4 · 2012: 3
FWCI
2.77
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Americanae (AECID Library) (submittedVersion, other-oa)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
Funders
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Keywords
fungemia, cancer patients, mortality risk factors, prognostic factors, neutropenia, performance status, Karnofsky performance status, age, central venous catheters, antifungal therapy, chemotherapy, radiotherapy, blood culture
MeSH terms
Adult, Aged, Female, Humans, Male, Middle Aged, Neoplasms, Prognosis, Risk Factors, Multivariate Analysis, Survival Analysis, Fungemia, Statistics, Nonparametric

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review